<th id="d13nf"><video id="d13nf"><ruby id="d13nf"></ruby></video></th>
<strike id="d13nf"></strike><strike id="d13nf"></strike>
<th id="d13nf"><video id="d13nf"></video></th>
<span id="d13nf"><video id="d13nf"></video></span>
<strike id="d13nf"></strike>
<span id="d13nf"></span>
<progress id="d13nf"><video id="d13nf"><strike id="d13nf"></strike></video></progress>
<span id="d13nf"><i id="d13nf"></i></span>
<span id="d13nf"><video id="d13nf"><strike id="d13nf"></strike></video></span>

For the latest updates on our ongoing response to COVID-19, please click here.

Saudi Arabia

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

What is an adverse event?

An adverse event (AE) is any undesirable experience associated with the use of a medical product.

What is pharmacovigilance?

Pharmacovigilance is the scientific practice of detecting, assessing, understanding and preventing adverse effects or any other drug-related problems.

Contact and reporting method:

The reporting of safety information following the authorization of a medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Anyone, who would like to report an adverse event, file a special situation report* or make a product quality complaint on a Gilead product, can contact our local agent, Cigalah Group, via the following channels:

Email: drug-safety@cigalah.com.sa

Telephone: +966 12 6148259 +966 12 6148259

Hotline: +966 (0) 539455825+966 (0) 539455825

*Special Situation Reports may include:

  • Pregnancy Report (maternal pregnancy and partner pregnancy; exposure via breastfeeding)
  • Abuse
  • Misuse
  • Medication Error (actual or potential)
  • Off-Label Use
  • Overdose
  • Lack of Effect
  • Occupational Exposure
  • Drug interactions
  • Unexpected Benefit
  • Counterfeit or Falsified Medicines
  • Transmission of Infectious Agents via the Product